Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Histone lysine demethylases (KDMs) are of critical importance in the epigenetic regulation of gene expression, yet there are few selective, cell-permeable inhibitors or suitable tool compounds for these enzymes. We describe the discovery of a new class of inhibitor that is highly potent towards the histone lysine demethylases KDM2A/7A. A modular synthetic approach was used to explore the chemical space and accelerate the investigation of key structure-activity relationships, leading to the development of a small molecule with around 75-fold selectivity towards KDM2A/7A versus other KDMs, as well as cellular activity at low micromolar concentrations.

Original publication




Journal article


Angew Chem Int Ed Engl

Publication Date





15555 - 15559


asymmetric catalysis, epigenetics, inhibitors, lysine demethylases, Dose-Response Relationship, Drug, Drug Discovery, Enzyme Inhibitors, F-Box Proteins, HeLa Cells, Humans, Jumonji Domain-Containing Histone Demethylases, Molecular Structure, Structure-Activity Relationship